Zoetis

Yahoo Finance • 4 days ago

How Investors May Respond To Zoetis (ZTS) Deepening Its Biologics Focus After World Vaccine Congress Update

Zoetis Inc. recently presented at the World Vaccine Congress Washington 2026 at the Walter E. Washington Convention Center, where Senior VP of Global Biologics R&D Mahesh Kumar highlighted the company’s latest vaccine research and developm... Full story

Yahoo Finance • 9 days ago

Do You Believe in Zoetis’ (ZTS) Long-Term Growth Potential?

Mairs & Power, an investment advisor, released the fourth-quarter 2025 investor letter for the “Mairs & Power Growth Fund.” A copy of the letter is available for download here. In 2025, artificial intelligence (AI) and market concentration... Full story

Yahoo Finance • 10 days ago

Vetr Announces Availability of Albendamax Amid National Shortage of Albendazole-Based Livestock Treatments

LAS VEGAS, NV / ACCESS Newswire / April 2, 2026 / Vetr, a veterinary health company focused on livestock treatment access, confirmed the availability of its albendazole-based product, Albendamax, as supply disruptions continue to affect wi... Full story

Yahoo Finance • 13 days ago

Worried About a Stock Market Crash? History Says Don't Sweat It.

Key Points The January barometer suggests the S&P 500 could be poised to rise in 2026. Research shows that U.S. markets are incredibly resilient, even in the face of "shock events." As The Motley Fool's co-founder, David Gardner, says, "S... Full story

Yahoo Finance • 13 days ago

Bristol Gate Capital Partners Sold Zoetis (ZTS) Due to Deteriorating Dividend Growth

Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. Bristol Gate prioritizes companies with strong free cash flow... Full story

Yahoo Finance • 25 days ago

What Makes Zoetis (ZTS) an Investment Bet?

Diamond Hill Capital, an investment management company, released its “Mid Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fourth quarter posted another period of favorable gains for equity ma... Full story

Yahoo Finance • last month

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 3.8% over the past six month... Full story

Yahoo Finance • last month

A Look At Zoetis (ZTS) Valuation After Recent Share Price Weakness

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Zoetis stock performance snapshot after recent weakness Zoetis (ZTS) has drawn fresh attention af... Full story

Yahoo Finance • last month

2 No-Brainer Dividend Stocks to Buy in 2026

Dividend stocks are not all the same. Some will readily decrease or suspend their payouts at the first sign of trouble, while others will continue increasing them even during market downturns or economic recessions. Dividend investors pre... Full story

Yahoo Finance • last month

Marvell upgraded, Trade Desk downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Piper Sandler upgraded Karman (KRMN) t... Full story

Yahoo Finance • last month

Jensen Quality Growth Equity Strategy Decided to Sell Its Stake in Zoetis (ZTS)

Jensen Investment Management, an asset management company based in the US, released its fourth-quarter investor letter for “Jensen Quality Growth Equity Strategy”. A copy of the letter can be downloaded here. The S&P 500 Index continued it... Full story

Yahoo Finance • last month

Jensen Quality Growth Equity Decided to Sell Accenture (ACN)

Jensen Investment Management, an asset management company based in the US, released its fourth-quarter investor letter for “Jensen Quality Growth Equity Strategy”. A copy of the letter can be downloaded here. The S&P 500 Index continued it... Full story

Yahoo Finance • last month

Thursday Sector Laggards: Healthcare, Industrial

Looking at the sectors faring worst as of midday Thursday, shares of Healthcare companies are underperforming other sectors, showing a 0.1% loss. Within that group, West Pharmaceutical Services, Inc. (Symbol: WST) and Zoetis Inc (Symbol:... Full story

Yahoo Finance • last month

Kevin O'Leary's 'Basepaws' Bet Proves Small, Weird Investments Can Drive Big Returns

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Quick Summary Kevin O'Leary once doubted a $29 cat DNA test on "Shark Tank," but his investment in Basepaws later became one of his most... Full story

Yahoo Finance • 2 months ago

Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory

We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on HalfBakedInnovations’s Substack by Biotech Distilled. In this article, we will summarize the bulls’ thesis on RARE. Ultragenyx Pharmaceutical Inc.'s share was trading at... Full story

Yahoo Finance • 2 months ago

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200

Healthcare is one of the most lucrative industries where investors can find world-class businesses to buy and hold. Industry leaders can be unstoppable long-term wealth creators, though there's no such thing as a perfect stock. Novo Nordis... Full story

Yahoo Finance • 2 months ago

Bank of America Cites Zoetis Inc.’s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook

Zoetis Inc. (NYSE:ZTS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds.Bank of America Cites Zoetis Inc.'s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook Zoetis Inc. (NYSE:ZTS) tops our list for being one o... Full story

Yahoo Finance • 2 months ago

Mairs and Power's Strategic Moves: NVIDIA Corp Sees a -1.1% Portfolio Impact

This article first appeared on GuruFocus. Exploring the Latest 13F Filing and Investment Strategies Mairs and Power (Trades, Portfolio) recently submitted their 13F filing for the fourth quarter of 2025, offering a glimpse into their str... Full story

Yahoo Finance • 2 months ago

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration. At the time of writing, the S&P 50... Full story

Yahoo Finance • 2 months ago

Stock Market Today, Feb. 12: Stocks moderate as initial claims fall, continuing claims rise

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Thursday. This is TheStreet’s Stock Market Today for Feb. 12, 2026. You c... Full story